Li Yao

188 Shizi Street
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Low initial hemoglobin and high-risk additional chromosomal abnormalities predict poor long-term survival in chronic phase chronic myeloid leukemia.

Low initial hemoglobin and high-risk additional chromosomal abnormalities predict poor long-term survival in chronic phase chronic myeloid leukemia.

Journal: Discover oncology

Published: October 18, 2025

Application of Targeted mRNA Sequencing in Fusion Genes Diagnosis of Hematologic Diseases

Application of Targeted mRNA Sequencing in Fusion Genes Diagnosis of Hematologic Diseases

Journal: Zhongguo shi yan xue ye xue za zhi

Published: September 11, 2025

Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma.

Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma.

Journal: Scientific reports

Published: December 28, 2024

Clonal evolution from B-cell acute lymphoblastic leukemia with BCR::ABL1 multilineage involvement to acute myeloid leukemia after multiple anti-CD19 chimeric antigen receptor T-cell therapy.

Clonal evolution from B-cell acute lymphoblastic leukemia with BCR::ABL1 multilineage involvement to acute myeloid leukemia after multiple anti-CD19 chimeric antigen receptor T-cell therapy.

Journal: Haematologica

Published: April 02, 2024

High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China.

High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China.

Journal: Annals of hematology

Published: February 21, 2024

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.

Journal: Discover oncology

Published: January 04, 2024

Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case.

Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case.

Journal: Molecular carcinogenesis

Published: October 30, 2023

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML.

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML.

Journal: Blood

Published: February 13, 2023

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase.

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase.

Journal: Frontiers in immunology

Published: August 06, 2022

Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases.

Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases.

Journal: Molecular carcinogenesis

Published: June 22, 2022

Identification of a recurrent fusion NUP98-RARG in acute myeloid leukaemia resembling acute promyelocytic leukaemia.

Identification of a recurrent fusion NUP98-RARG in acute myeloid leukaemia resembling acute promyelocytic leukaemia.

Journal: British journal of haematology

Published: December 11, 2021

Clinical Response to Venetoclax and Decitabine in Acute Promyelocytic Leukemia With a Novel RARA-THRAP3 Fusion: A Case Report.

Clinical Response to Venetoclax and Decitabine in Acute Promyelocytic Leukemia With a Novel RARA-THRAP3 Fusion: A Case Report.

Journal: Frontiers in oncology

Published: December 04, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026